Profile and Organisation

Names | Figures | Facts

Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.

Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing mankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.

We are committed to operating sustainably and addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Bayer.

All this is part of our mission:

Bayer: Science For A Better Life

Exclusive Focus on the Life Science Businesses

Following the economic and legal independence of our former MaterialScience subgroup, now Covestro*, Bayer has charted the course for its successful development as a Life Science company. Our Life Science businesses hold leading positions in innovation-driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks.

The previous structure – comprising a strategic management holding company and operational subgroups – has thus been replaced by an integrated organization under the umbrella of the strong Bayer brand. The company’s operations are managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit.

The business continues to be supported by the corporate functions, Bayer Business Services and the service company Currenta, while Technology Services is being integrated into Bayer AG, forming the Engineering and Technology function.

Organization of Bayer

Business Operations Are the Responsibility of the Divisions

The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.

The Consumer Health Division markets mainly non-prescription products in the mother and baby, multivitamins and supplements, pain relief, cough-cold, allergy, gastrointestinal and anti-fungal categories. These products include globally known brands such as Elevit™, Berocca™, Canesten™, Claratyne™, Nasonex Allergy™, Demazin™ and Iberogast™.

The Crop Science Division has businesses in seeds, crop protection and non-agricultural pest control. It is organised into two operating units: Crop Protection/Seeds and Environmental Science. Crop Protection/Seeds markets a broad portfolio of high-value seeds along with innovative chemical and biological pest management solutions, at the same time providing extensive customer service for modern and sustainable agriculture. Environmental Science focuses on non-agricultural applications, with a broad portfolio of pest control products and services for areas ranging from the home and garden sector to forestry.

The Animal Health Business Unit offers products and services for the prevention and treatment of diseases in companion and farm animals.

Central Service Functions

The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.

Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.

Covestro* is a leading supplier of high-tech polymer materials and develops innovative product solutions for a wide variety of everyday uses.

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:

seven members, Chairman: Werner Baumann

Supervisory Board:

20 members, Chairman: Werner Wenning



With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly ageing world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.


Best-selling Bayer products are:

  • in the health care field: Xarelto™, Kogenate™, Betaferon™/Betaseron™/Mirena product family , Nexavar™
  • The key brands in the agriculture field are: Confidor™ / Gaucho™, Nativo™ product family, Nunhems™, Basta™/ Liberty™, Prosaro™ product family




The Bayer Group comprises around 301 consolidated companies** in 78 countries throughout the world. Global headquarters are in Leverkusen, Germany.

** fully consolidated subsidiaries (as of Dec. 31, 2015)


Our Employees

On December 31, 2016, the Bayer Group had 115,200 employees worldwide.

Employees by region and gender

Bayer Stock

Bayer Group Key Data

  2015 2016 Change
  € million € million %
Bayer Group      
Sales 46,085 46,769 +1.5
EBIT1 6,241 7,042 +12.8
EBIT before special items2 7,060 8,130 +15.2
EBITDA3 9,573 10,785 +12.7
EBITDA before special items2 10,256 11,302 +10.2
EBITDA margin before special items4 22.3% 24.2%  
Income before income taxes 5,236 5,887 +12.4
Net income 4,110 4,531 +10.2
Earnings per share (€)5 4.97 5.44 +9.5
Core earnings per share (€)6 6.82 7.32 +7.3
Net financial debt 17,449 11,778 -32.5
Capital expenditures as per segment table 2,511 2,578 +2.7
Research and development expenses 4,274 4,666 +9.2
Dividend per Bayer AG share (€) 2.50 2.70 +8.0

figures restated
1-6 for definition see footnotes to Bayer Group Key Data table

(as of Dec. 31, 2016)